Literature DB >> 9266811

Therapeutic use of butyrylcholinesterase for cocaine intoxication.

C E Mattes1, T J Lynch, A Singh, R M Bradley, P A Kellaris, R O Brady, K L Dretchen.   

Abstract

The most common complications of cocaine ingestion are on the cardiovascular and central nervous systems and produce chest pain and generalized seizures. In humans, decreased levels of butyrylcholinesterase (BChE) (EC 3.1.1.8) have been associated with sustained effects of cocaine and life-threatening complications. Administration of purified human BChE has previously been demonstrated to protect against cocaine-associated cardiovascular toxicity in rats. A shift in the metabolism of cocaine as well as enhanced metabolism may be the underlying mechanism of the enzyme. Therefore, levels of the parent drug and four metabolites were determined in rat plasma after i.p. administration of a lethal cocaine dose, followed by i.v. administration of BChE. Plasma and brain concentrations of cocaine were lowered by 80% after BChE administration. Furthermore, the metabolic profile of cocaine in the plasma was altered. The concentration of ecgonine methylester was doubled although the concentration of ecgonine, a secondary metabolite of cocaine, was reduced. The level of benzoylecgonine was reduced by one-half while norcocaine was absent. Cocaine-associated effects upon the central nervous system were also shown to be reduced by administration of BChE to conscious rats. Furthermore, our studies in the cat have also shown that purified BChE shifts the metabolic profile of cocaine (1 mg/kg) to the pharmacologically inactive products ecgonine methylester and ecgonine. Pretreatment with BChE (0.27, 1.0, and 10.0 mg/kg) ameliorated the hypertensive effects of cocaine (1 mg/kg) by reducing the duration and the extent of BP elevation by 66%. Administration of the enzyme, 1 min after cessation of cocaine infusion, resulted in an immediate attenuation in the cocaine-induced broadening of the QRS complex. These results suggest that BChE could be an effective and rapid therapy for the treatment of life-threatening cocaine-induced cardiovascular effects in human while clearing the total body burden of cocaine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266811     DOI: 10.1006/taap.1997.8188

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  16 in total

Review 1.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Toward cocaine esterase therapeutics.

Authors:  Claude J Rogers; Jenny M Mee; Gunnar F Kaufmann; Tobin J Dickerson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2005-07-20       Impact factor: 15.419

3.  Cryo-EM structure of the native butyrylcholinesterase tetramer reveals a dimer of dimers stabilized by a superhelical assembly.

Authors:  Miguel Ricardo Leung; Laura S van Bezouwen; Lawrence M Schopfer; Joel L Sussman; Israel Silman; Oksana Lockridge; Tzviya Zeev-Ben-Mordehai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-11       Impact factor: 11.205

Review 4.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

5.  Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys.

Authors:  Charles W Schindler; Zuzana Justinova; David Lafleur; Doug Woods; Viktor Roschke; Hussein Hallak; Liora Sklair-Tavron; Godfrey H Redhi; Sevil Yasar; Jack Bergman; Steven R Goldberg
Journal:  Addict Biol       Date:  2012-01-20       Impact factor: 4.280

6.  Structural analysis of thermostabilizing mutations of cocaine esterase.

Authors:  Diwahar Narasimhan; Mark R Nance; Daquan Gao; Mei-Chuan Ko; Joanne Macdonald; Patricia Tamburi; Dan Yoon; Donald M Landry; James H Woods; Chang-Guo Zhan; John J G Tesmer; Roger K Sunahara
Journal:  Protein Eng Des Sel       Date:  2010-04-30       Impact factor: 1.650

7.  Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase.

Authors:  Daquan Gao; Chang-Guo Zhan
Journal:  Proteins       Date:  2006-01-01

8.  Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.

Authors:  Adel Hamza; Hoon Cho; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2005-03-17       Impact factor: 2.991

9.  A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse.

Authors:  Remy L Brim; Mark R Nance; Daniel W Youngstrom; Diwahar Narasimhan; Chang-Guo Zhan; John J G Tesmer; Roger K Sunahara; James H Woods
Journal:  Mol Pharmacol       Date:  2010-01-19       Impact factor: 4.436

10.  Treating cocaine addiction with viruses.

Authors:  M Rocio A Carrera; Gunnar F Kaufmann; Jenny M Mee; Michael M Meijler; George F Koob; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.